SEC Form 4 · accession 0001127602-15-022832
PALL CORP · PLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Egholm
Officer — President, BioPharmaceuticals
Period of report
Jul 13, 2015
Accepted (ET)
Jul 15, 2015 · 3:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075829
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2015 | M | 1,595 | $125.52 | A | 1,596 | D | |
| Common Stock | Jul 13, 2015 | F | 662 | $125.52 | D | 934 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jul 15, 2015 | M | 1,595 | D | Jul 13, 2011 | Jul 13, 2015 | Common Stock | 1,595 | 0 | D |
Explanation of responses
- F1The Units vested and converted into shares of Common Stock of the Issuer on a one-for-one basis on July 13, 2015, provided the Reporting Person satisfied certain service conditions.
- F2Date shown is date of grant. These restricted stock units vested on the fourth anniversary of the grant date provided the reporting person satisfied certain service conditions.